Active substanceAceclofenacAceclofenac
Similar drugsTo uncover
  • Alental®
    pills inwards 
    VERTEKS, AO     Russia
  • Asinak
    pills inwards 
  • Atsklagin®
    pills inwards 
  • Aceclofenac
    pills inwards 
    VELFARM, LLC     Republic of San Marino
  • Aertal®
    powder inwards 
    Almiral S.A.     Spain
  • Aertal®
    cream externally 
    Almiral S.A.     Spain
  • Aertal®
    pills inwards 
    Almiral S.A.     Spain
  • Dosage form: & nbspfilm coated tablets
    Composition:

    Each tablet contains:

    Active substance: aceclofenac 100 mg

    Excipients: Cellulose microcrystalline, starch, silicon dioxide colloid, talc purified, magnesium stearate, croscarmellose sodium.

    Sheath: Coating instakoat IS-S-010 white {hypromellose, macrogol, purified talc, titanium dioxide).

    Description:

    Round, biconvex tablets, covered with a film coat of white color, smooth on both sides.

    Pharmacotherapeutic group:Non-steroidal anti-inflammatory drug (NSAID)
    ATX: & nbsp

    M.01.A.B   Derivatives of acetic acid

    M.01.A.B.16   Aceclofenac

    Pharmacodynamics:

    Aceclofenac is a derivative of phenylacetic acid, selectively inhibits cyclooxygenase I and II types. Aceclofenac has anti-inflammatory, analgesic and antipyretic effects. Oppresses the synthesis of prostaglandins and, thus, affects the pathogenesis of inflammation.the occurrence of pain and fever. In rheumatic diseases, the anti-inflammatory and analgesic effect of aceclofenac contributes to a significant reduction in the severity of pain, morning stiffness, swelling of the joints, which improves the functional state of the patient.

    Pharmacokinetics:

    Aceclofenac is rapidly and completely absorbed after ingestion. The time to reach the maximum concentration is 1.25-3 hours. It penetrates into the synovial fluid, where its concentration reaches 57% of the concentration in the plasma and the time to reach the maximum concentration 2-4 hours later than in the plasma. The volume of distribution is 25 liters.

    The connection with plasma proteins (albumins) is 99%. Aceclofenac circulates the main in an unchanged form, its main metabolite is 4'-hydroxyacetofenac.

    The half-life is 4 hours. It is excreted by the kidneys, mainly in the form of hydroxy derivatives (about 2/3 introduced dose).

    Indications:

    Symptomatic treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis. It is intended for symptomatic therapy, reducing pain and inflammation at the time of use, the progression of the disease is not affected.

    Contraindications:

    - Erosive-ulcerative lesions of the gastrointestinal tract in the phase of cattletrhenium, gastrointestinal bleeding or suspicion of it;

    - complete or incomplete combination of bronchial asthma, recurring pollinosis of the nasal mucosa and paranasal sinuses and intolerance to acetylsalicylic acid or other NSAIDs (including in the anamnesis);

    - hypersensitivity to aceclofenac or drug components;

    - period after aortocoronary shunting;

    - severe hepatic impairment or active liver disease;

    - inflammatory bowel disease (Crohn's disease, ulcerative colitis) in the phase of exacerbation;

    - Decompensated heart failure;

    - disorders of blood formation and clotting of blood;

    - severe renal failure, progressive kidney disease, hyperkalemia;

    - pregnancy and lactation;

    - children's age till 18 years.

    Carefully:

    Diseases of the liver, kidneys and gastrointestinal tract in history, bronchial asthma, arterial hypertension, a decrease in the volume of circulating blood (including immediately after extensive surgical interventions), coronary heart disease,mild to moderate chronic renal failure, mild to moderate liver failure, heart failure, cerebrovascular disease, dyslipidemia / hyperlipidemia, diabetes mellitus, peripheral arterial disease, smoking, advanced age, prolonged history of use of NSAIDs, frequent alcohol use, concomitant therapy with the following drugs:

    - anticoagulants (for example, warfarin)

    - antiaggregants (eg, acetylsalicylic acid, clopidogrel),

    - oral glucocorticosteroids (for example, prednisolone),

    - selective serotonin reuptake inhibitors (eg, citalopram, fluoxetine, paroxetine, sertraline).

    Pregnancy and lactation:
    Dosing and Administration:

    Inside. Tablets should be swallowed entirely, with enough liquid.

    Usually adults are prescribed 1 tablet by 100 mg 2 times a day; one tablet in the morning and one in the evening.

    A minimum effective dose should be used with the minimum possible short course.
    Side effects:

    From the gastrointestinal tract: nausea, vomiting, diarrhea, pain in the epigastric region, intestinal colic, dyspepsia, flatulence, anorexia, constipation; at In rare cases, erosive and ulcerative lesions, bleeding and perforation of the gastrointestinal tract (hematemesis, melena), stomatitis at including aphthous, pancreatitis.

    From the nervous system: Sometimes there is headache, dizziness, sleep disturbances (insomnia or drowsiness), excitement, in some cases marked sensitivity disorders, disorientation, memory, vision, hearing, taste, tinnitus, convulsions, irritability, tremor, depression, anxiety, vertigo, aseptic meningitis, paresthesia.

    Allergic manifestations: sometimes there is a skin rash, seldom - hives, individual cases of eczema, polymorphic erythema, erythroderma, rarely had attacks of bronchial asthma; systemic anaphylactic reactions, in some cases, vasculitis, pneumonitis, Stevens-Johnson syndrome and Lyell syndrome, anaphylactic shock.

    From the side of the kidneys: rarely peripheral edema, in some cases, acute renal failure, interstitial nephritis, nephrotic syndrome, hematuria, proteinuria.

    From the side of the liver: transient increase in transaminase activity in the blood, rarely - hepatitis, in some cases fulminant hepatitis.

    On the part of the hematopoiesis system: leukopenia, described individual cases of thrombocytopenia, agranulocytosis, hemolytic anemia, aplastic anemia.

    From the cardiovascular system: single cases of tachycardia, hypertension, congestive heart failure, IHD.

    Overdose:Symptoms:

    The clinical picture is determined by violations from the central nervous system (headache, dizziness, hyperventilation with increased convulsive readiness) and gastrointestinal disorders (abdominal pain, nausea, vomiting).

    Treatment:

    In case of an overdose, gastric lavage, administration of activated charcoal, symptomatic therapy are indicated. There is no specific antidote. Forced diuresis, hemodialysis, blood transfusion - ineffective.

    Interaction:

    With simultaneous application of Asinak and:

    - digoxin, phenytoin, or lithium preparations - the plasma content of these drugs may increase;

    - diuretics and antihypertensive drugs - the effect of these drugs may be weakened;

    - other NSAIDs or glucocorticosteroids - there is an increased risk of side effects from the gastrointestinal tract;

    - selective serotonin reuptake inhibitors (citalopram, fluoxetine, paroxetine, sertraline) - increase the risk of bleeding from the gastrointestinal tract;

    - cyclosporine - may increase the toxic effect of the latter on the kidneys; - hypoglycemic agents - can cause both hypo- and hyperglycemia. With this combination of drugs, glucose control in blood;

    - Methotrexate within 24 hours before or after its administration - may lead to an increase in the concentration of methotrexate and to an increase him toxic effect;

    - antiplatelet agents and anticoagulants - the risk of bleeding increases (regular coagulation monitoring is necessary).

    Special instructions:

    During the treatment with the drug should be a systematic control of the picture of peripheral blood, liver function, kidneys, examination of feces for the presence of blood. The drug has a symptomatic effect without affecting the progression of the disease.

    If there are signs of liver damage (skin itching, jaundice, nausea, vomiting, abdominal pain, darkening of urine, increased activity of liver transaminases), stop taking the drug and consult a doctor.

    Do not use the drug simultaneously with other NSAIDs.

    The drug can change the properties of platelets, but does not replace the preventive effect of acetylsalicylic acid in cardiovascular diseases.

    The use of the drug may adversely affect female fertility and is not recommended for women planning pregnancy.

    After 2 weeks of using the drug, it is necessary to monitor the indicators of liver function ("transaminase"). To reduce the risk of developing adverse events on the part of the gastrointestinal tract, a minimum effective dose should be used with the minimum possible short course. You should avoid the simultaneous use of alcohol.

    Effect on the ability to drive transp. cf. and fur:Patients in whom the intake of NSAIDs caused side effects that could affect the concentration of attention and the speed of mental and motor reactions, it is necessary to refrain from driving motor vehicles.
    Form release / dosage:Tablets, film-coated, 100 mg each.
    Packaging:

    10 tablets per blister from Al / Al. For 1, 3 or 10 blisters together with instructions for use in a pack of cardboard.

    Storage conditions:

    At a temperature of no higher than 25 ° C, in a dry place.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use the drug with expired shelf life.
    Terms of leave from pharmacies:On prescription
    Registration number:LSR-002167/10
    Date of registration:17.03.2010
    Expiration Date:Unlimited
    The owner of the registration certificate:Medley Pharmaceuticals, Ltd. Medley Pharmaceuticals, Ltd. India
    Manufacturer: & nbsp
    Information update date: & nbsp18.09.2017
    Illustrated instructions
      Instructions
      Up